Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05245071
Title Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA (CARMEN-LC06)
Acronym CARMEN-LC06
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sanofi
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | BEL

Facility Status City State Zip Country Details
Roswell Park Cancer Institute Site Number : 8400004 Buffalo New York 14263 United States Details
Renovatio Clinical Site Number : 8400003 El Paso Texas 79915 United States Details
Investigational Site Number : 0560003 Edegem 2650 Belgium Details
Investigational Site Number : 0560001 Leuven 3000 Belgium Details
Investigational Site Number : 0560002 Liege 4000 Belgium Details
Investigational Site Number : 2500003 Bordeaux 33076 France Details
Investigational Site Number : 2500001 Creteil 94010 France Details
Investigational Site Number : 2500007 Marseille 13015 France Details
Investigational Site Number : 2500005 Montpellier 34295 France Details
Investigational Site Number : 2500002 RENNES Cedex 09 35033 France Details
Investigational Site Number : 2500006 Saint Herblain 44800 France Details
Investigational Site Number : 2500008 Saint-mande 94160 France Details
Investigational Site Number : 2500009 Villejuif 94800 France Details
Investigational Site Number : 3800003 Ravenna Emilia-Romagna 48121 Italy Details
Investigational Site Number : 3800004 Aviano (PN) Friuli-Venezia Giulia 33081 Italy Details
Investigational Site Number : 3800001 Rozzano Lombardia 20089 Italy Details
Investigational Site Number : 3800002 Milano 20133 Italy Details
Investigational Site Number : 3920002 Nagoya-shi Aichi 460-0001 Japan Details
Investigational Site Number : 3920001 Sapporo-shi Hokkaido 003-0804 Japan Details
Investigational Site Number : 3920005 Hirakata-shi Osaka 573-1191 Japan Details
Investigational Site Number : 3920003 Sunto Gun Shizuoka 411-8777 Japan Details
Investigational Site Number : 7240004 Barcelona Barcelona [Barcelona] 08028 Spain Details
Investigational Site Number : 7240006 Barcelona Barcelona [Barcelona] 08036 Spain Details
Investigational Site Number : 7240001 Hospitalet de Llobregat Barcelona [Barcelona] 08908 Spain Details
Investigational Site Number : 7240009 Madrid / Madrid Madrid, Comunidad De 28040 Spain Details
Investigational Site Number : 7240002 Madrid Madrid, Comunidad De 28041 Spain Details
Investigational Site Number : 7240008 Majadahonda Madrid 28222 Spain Details
Investigational Site Number : 7240003 Málaga 29010 Spain Details
Investigational Site Number : 7240005 Sevilla 41013 Spain Details
Investigational Site Number : 7240007 Valencia 46026 Spain Details
Investigational Site Number : 7920002 Adana 01120 Turkey Details
Investigational Site Number : 7920005 Ankara 06800 Turkey Details
Investigational Site Number : 7920003 Istanbul 34300 Turkey Details
Investigational Site Number : 7920004 Istanbul 34722 Turkey Details
Investigational Site Number : 7920001 Malatya Turkey Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field